HomeVERV • NASDAQ
add
Verve Therapeutics Inc
Previous close
$6.01
Day range
$5.41 - $5.88
Year range
$4.31 - $19.34
Market cap
468.19M USD
Avg Volume
1.56M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 6.86M | 120.24% |
Operating expense | 13.84M | 18.41% |
Net income | -50.13M | -9.56% |
Net profit margin | -730.27 | 50.25% |
Earnings per share | -0.59 | 18.06% |
EBITDA | -55.16M | -8.45% |
Effective tax rate | -0.21% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 539.92M | 11.27% |
Total assets | 663.91M | 8.41% |
Total liabilities | 155.36M | 2.18% |
Total equity | 508.55M | — |
Shares outstanding | 84.66M | — |
Price to book | 1.00 | — |
Return on assets | -20.85% | — |
Return on capital | -23.74% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -50.13M | -9.56% |
Cash from operations | -39.61M | -235.34% |
Cash from investing | 56.81M | 580.07% |
Cash from financing | 14.00K | -99.96% |
Net change in cash | 17.22M | 108.01% |
Free cash flow | -23.33M | 4.55% |
About
Founded
2018
Headquarters
Website
Employees
255
